{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:35Z","timestamp":1793995595667,"version":"4.8.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The liver is in charge of a wide range of critical physiological processes and it plays an important role in activating the innate immune system which elicits the inflammatory events. Chronic ethanol exposure disrupts hepatic inflammatory mechanism and leads to the release of proinflammatory mediators such as chemokines, cytokines and activation of inflammasomes. The mechanism of liver fibrosis\/cirrhosis involve activation of NLRP3 inflammasome, leading to the destruction of hepatocytes and subsequent metabolic dysregulation in humans. In addition, increasing evidence suggests that alcohol intake significantly modifies liver epigenetics, promoting the development of alcoholic liver disease (ALD). Epigenetic changes including histone modification, microRNA-induced genetic modulation, and DNA methylation are crucial in alcohol-evoked cell signaling that affects gene expression in the hepatic system. Though we are at the beginning stage without having the entire print of epigenetic signature, it is time to focus more on NLRP3 inflammasome and epigenetic modifications. Here we review the novel aspect of ALD pathology linking to inflammation and highlighting the role of epigenetic modification associated with NLRP3 inflammasome and how it could be a therapeutic target in ALD.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1215333","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T20:59:06Z","timestamp":1689281946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["NLRP3: a new therapeutic target in alcoholic liver disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Subhashini","family":"Brahadeeswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiasha","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatraman","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Saraswathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramasamy","family":"Tamizhselvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i40.14652","article-title":"Alcoholic disease: liver and beyond","volume":"20","author":"Rocco","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B3","article-title":"The epidemiology of alcoholic liver disease","volume":"27","author":"Mann","year":"2003","journal-title":"Alcohol Res Heal J Natl Inst Alcohol Abus Alcohol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/BF02233094","article-title":"Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis","volume":"13","author":"Mendenhall","year":"1968","journal-title":"Am J Dig Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2012.08.002","article-title":"Alcohol metabolism","volume":"16","author":"Cederbaum","year":"2012","journal-title":"Clin Liver Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph7041285","article-title":"Alcohol and acetaldehyde in public health: from marvel to menace","volume":"7","author":"Guo","year":"2010","journal-title":"Int J Environ Res Public Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-072610-145138","article-title":"Inflammation in alcoholic liver disease","volume":"32","author":"Wang","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3015","article-title":"Therapeutic strategies for alcoholic liver disease: focusing on inflammation and fibrosis (Review)","volume":"40","author":"Kawaratani","year":"2017","journal-title":"Int J Mol Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discovery"},{"key":"B12","doi-asserted-by":"publisher","first-page":"111428","DOI":"10.1016\/j.biopha.2021.111428","article-title":"The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases","volume":"138","author":"Feng","year":"2021","journal-title":"BioMed \\& Pharmacother = BioMed \\& Pharmacother"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3AB1214-590R","article-title":"Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease","volume":"98","author":"Petrasek","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2012.06.005","article-title":"DNA Methylation: a promising landscape for immune system-related diseases","volume":"28","author":"Suarez-Alvarez","year":"2012","journal-title":"Trends Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr685","article-title":"A promoter DNA demethylation landscape of human hematopoietic differentiation","volume":"40","author":"Calvanese","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601102","article-title":"Epigenetic networks regulate the transcriptional program in memory and terminally differentiated CD8+ T cells","volume":"198","author":"Rodriguez","year":"2017","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.it.2018.11.006","article-title":"Therapeutic epigenetic reprogramming of trained immunity in myeloid cells","volume":"40","author":"Rodriguez","year":"2019","journal-title":"Trends Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/biomedicines9111614","article-title":"An epigenetic insight into NLRP3 inflammasome activation in inflammation-related processes","volume":"9","author":"Raneros","year":"2021","journal-title":"Biomedicines"},{"key":"B20","article-title":"Chapter 21 - alcohol and epigenetic modulations","volume-title":"Patel VBBT-MA of a and n","author":"D\u2019Addario","year":"2016"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1210","article-title":"Biochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteins","volume":"65","author":"MacDonald","year":"2013","journal-title":"IUBMB Life"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.21-0002","article-title":"PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway","volume":"70","author":"Liu","year":"2021","journal-title":"Exp Anim"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200179200","article-title":"The PYRIN-CARD protein ASC is an activating adaptor for caspase-1","volume":"277","author":"Srinivasula","year":"2002","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.mie.2019.04.024","article-title":"Chapter seven - monitoring gasdermin pore formation in vitro","volume-title":"DNA Sensors and inflammasomes","author":"Xia","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/mmr.2021.12556","article-title":"IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis","volume":"25","author":"Li","year":"2022","journal-title":"Mol Med Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41509.x","article-title":"Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease","volume":"100","author":"Latvala","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","article-title":"IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family","volume":"103","author":"Dinarello","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/livers1020007","article-title":"The impact of the NLRP3 pathway in the pathogenesis of non-alcoholic fatty liver disease and alcohol-related liver disease","volume":"1","author":"Sheriff","year":"2021","journal-title":"Livers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02014","article-title":"Interleukin-1 family cytokines: keystones in liver inflammatory diseases","volume":"10","author":"Barbier","year":"2019","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02201","article-title":"Inflammasome: a double-edged sword in liver diseases","volume":"9","author":"Luan","year":"2018","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2012.00077","article-title":"Inflammasome-IL-1\u03b2 signaling mediates ethanol inhibition of hippocampal neurogenesis","volume":"6","author":"Crews","year":"2012","journal-title":"Front Neurosci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.3390\/ijms22158221","article-title":"CYP2E1 in alcoholic and non-alcoholic liver injury. roles of ROS, reactive intermediates and lipid overload","volume":"22","author":"Harjum\u00e4ki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2609","article-title":"Relationship between oxidative stress and hepatic glutathione levels in ethanol-mediated apoptosis of polarized hepatic cells","volume":"15","author":"McVicker","year":"2009","journal-title":"World J Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318259d38e","article-title":"Endoplasmic reticulum stress modulates liver inflammatory immune response in the pathogenesis of liver ischemia and reperfusion injury","volume":"94","author":"Liu","year":"2012","journal-title":"Transplantation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.552141","article-title":"High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD)","volume":"289","author":"Ge","year":"2014","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.896473","article-title":"Inflammasomes and pyroptosis of liver cells in liver fibrosis","volume":"13","author":"Gan","year":"2022","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20957","article-title":"Alcohol and oxidative liver injury","volume":"43","author":"Dey","year":"2006","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2183026","DOI":"10.1155\/2016\/2183026","article-title":"ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis Ischemia\/Reperfusion injury","volume":"2016","author":"Minutoli","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00736-9","article-title":"The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases","volume":"12","author":"Chang","year":"2022","journal-title":"Cell Biosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180814","article-title":"Thioredoxin-interacting protein (TXNIP) associated NLRP3 inflammasome activation in human alzheimer\u2019s disease brain","volume":"68","author":"Li","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000099261.87880.21","article-title":"Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes","volume":"27","author":"Valles","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): summary of a gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6495793","article-title":"The role of IL-1 family members and kupffer cells in liver regeneration","volume":"2016","author":"Tan","year":"2016","journal-title":"BioMed Res Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2749","article-title":"Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity","volume":"14","author":"Hara","year":"2013","journal-title":"Nat Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.831004","article-title":"Cell-to-Cell communications in alcohol-associated liver disease","volume":"13","author":"Osna","year":"2022","journal-title":"Front Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.11.009","article-title":"NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice","volume":"534","author":"Wang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J Cell Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2017.1327965","article-title":"Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease","volume":"39","author":"Bahabadi","year":"2017","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12570","article-title":"The pan-caspase inhibitor emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis","volume":"35","author":"Barreyro","year":"2015","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s11418-018-01275-3","article-title":"Andrographolide impairs alpha-naphthylisothiocyanate-induced cholestatic liver injury in vivo","volume":"73","author":"Wang","year":"2019","journal-title":"J Nat Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.11.008","article-title":"Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease","volume":"72","author":"Majdi","year":"2020","journal-title":"J Hepatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JIR.S129027","article-title":"Epigenetics of chronic inflammatory diseases","volume":"12","author":"Stylianou","year":"2019","journal-title":"J Inflammation Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat Rev Genet"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i33.5265","article-title":"Epigenetic effects of ethanol on liver and gastrointestinal injury","volume":"12","author":"Shukla","year":"2006","journal-title":"World J gastroenterol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.186775","article-title":"Histone H3 phosphorylation (Ser10, Ser28) and phosphoacetylation (K9S10) are differentially associated with gene expression in liver of rats treated in vivo with acute ethanol","volume":"340","author":"James","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"B70","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease","volume":"20","author":"Greenberg","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jaci.2016.05.016","article-title":"DNA Demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes","volume":"139","author":"Vento-Tormo","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"43232381","DOI":"10.1155\/2016\/4323281","article-title":"NLRP3 activation was regulated by DNA methylation modification during mycobacterium tuberculosis infection","volume":"2016","author":"Wei","year":"2016","journal-title":"BioMed Res Int"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4256","article-title":"Epigenetic inactivation of the candidate tumor suppressor gene ASC\/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4447","article-title":"Hypermethylation of ASC\/TMS1 is a sputum marker for late-stage lung cancer","volume":"66","author":"Machida","year":"2006","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-006-9264-4","article-title":"Hypermethylation of the proapoptotic gene TMS1\/ASC: prognostic importance in glioblastoma multiforme","volume":"82","author":"Martinez","year":"2007","journal-title":"J Neurooncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12094-015-1367-y","article-title":"Methylation of ASC\/TMS1 promoter is associated with poor prognosis of patients with gastric cancer","volume":"18","author":"Wu","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4172\/2329-6488.1000259","article-title":"Epigenetic interactions between alcohol and cannabinergic effects: focus on histone modification and DNA methylation","volume":"5","author":"Parira","year":"2017","journal-title":"J Alcohol Drug Depend"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.celrep.2020.01.030","article-title":"Targeting macrophage histone H3 modification as a leishmania strategy to dampen the NF-\u03baB\/NLRP3-Mediated inflammatory response","volume":"30","author":"Lecoeur","year":"2020","journal-title":"Cell Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2018.01.011","article-title":"Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib","volume":"302","author":"Liu","year":"2018","journal-title":"Exp Neurol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmet.2020.01.009","article-title":"An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance","volume":"31","author":"He","year":"2020","journal-title":"Cell Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0490-7","article-title":"Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation","volume":"42","author":"Song","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13338","article-title":"Emerging role of epigenetic mechanisms in alcohol addiction","volume":"41","author":"Berkel","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5731-07.2008","article-title":"Brain chromatin remodeling: a novel mechanism of alcoholism","volume":"28","author":"Pandey","year":"2008","journal-title":"J Neurosci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2008.00630.x","article-title":"Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase","volume":"32","author":"Choudhury","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145714001047","article-title":"Effects of acute ethanol exposure on anxiety measures and epigenetic modifiers in the extended amygdala of adolescent rats","volume":"17","author":"Sakharkar","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"B86","first-page":"47","article-title":"Epigenetic effects of ethanol on the liver and gastrointestinal system","volume":"35","author":"Shukla","year":"2013","journal-title":"Alcohol Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28907","article-title":"MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced parkinson\u2019s disease mouse model","volume":"234","author":"Sun","year":"2019","journal-title":"J Cell Physiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of parkinson\u2019s disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol Neurodegener"},{"key":"B89","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1159\/000493042","article-title":"MicroRNA-495 ameliorates cardiac microvascular endothelial scell injury and inflammatory reaction by suppressing the NLRP3 inflammasome signaling pathway","volume":"49","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.381","article-title":"MiR-22 sustains NLRP3 expression and attenuates h. pylori-induced gastric carcinogenesis","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646665","article-title":"Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression","volume":"47","author":"Garstkiewicz","year":"2017","journal-title":"Eur J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315123","article-title":"Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression","volume":"68","author":"Heo","year":"2019","journal-title":"Gut"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.06.004","article-title":"Hypermethylation of the micro-RNA 145 promoter is the key regulator for NLRP3 inflammasome-induced activation and plaque formation","volume":"3","author":"Wei","year":"2018","journal-title":"JACC Basic to Transl Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-00508-y","article-title":"Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin","volume":"101","author":"Yang","year":"2021","journal-title":"Lab Invest"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.03.011","article-title":"Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation","volume":"11","author":"Lv","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.12.027","article-title":"Sirtuin 3-induced macrophage autophagy in regulating NLRP3 inflammasome activation","volume":"1864","author":"Liu","year":"2018","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i20.2456","article-title":"Epigenetic regulation in alcoholic liver disease","volume":"17","author":"Mandrekar","year":"2011","journal-title":"World J Gastroenterol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.05.042","article-title":"Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression","volume":"68","author":"Rahman","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1053\/j.seminhematol.2005.05.002","article-title":"Pharmacology of 5-Aza-2\u2019-deoxycytidine (decitabine)","volume":"42","author":"Momparler","year":"2005","journal-title":"Semin Hematol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jnci\/95.5.399","article-title":"Inhibition of DNA methylation and reactivation of silenced genes by zebularine","volume":"95","author":"Cheng","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3816\/CGC.2007.n.029","article-title":"Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy","volume":"5","author":"Amato","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2957","article-title":"Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases","volume":"65","author":"Brueckner","year":"2005","journal-title":"Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J Biol Chem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J Biol Chem"},{"key":"B105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/GEG.S12270","article-title":"Use of epigenetic drugs in disease: an overview","volume":"6","author":"Heerboth","year":"2014","journal-title":"Genet Epigenet"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2010.03.006","article-title":"Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor","volume":"17","author":"Bowers","year":"2010","journal-title":"Chem Biol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-2026-y","article-title":"Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents","volume":"142","author":"Xue","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-387365","article-title":"Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma","volume":"119","author":"Santo","year":"2012","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.594437","article-title":"Romidepsin: a novel histone deacetylase inhibitor for cancer","volume":"20","author":"Bertino","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"B110","doi-asserted-by":"publisher","first-page":"107880","DOI":"10.1016\/j.pharmthera.2021.107880","article-title":"Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis","volume":"227","author":"Shao","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12908","article-title":"Therapeutic modulation of inflammasome pathways","volume":"297","author":"Chauhan","year":"2020","journal-title":"Immunol Rev"},{"key":"B112","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"127571","DOI":"10.1016\/j.bmcl.2020.127571","article-title":"Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor","volume":"30","author":"Agarwal","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat Commun"},{"key":"B117","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41419-021-04240-3","article-title":"A long way to go: caspase inhibitors in clinical use","volume":"12","author":"Dhani","year":"2021","journal-title":"Cell Death Dis"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-Approved disulfiram inhibits pyroptosis by blocking gasdermin d pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1215333\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T20:59:13Z","timestamp":1689281953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1215333\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":118,"alternative-id":["10.3389\/fimmu.2023.1215333"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1215333","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"article-number":"1215333"}}